Injective's native token INJ rose about 3.2% to $7.70 on Binance on November 13, after buyers stepped in near the $7.33 Fibonacci support and pushed the price back above its 50-day exponential moving average. The intraday low was $7.14, below the 0.382 retracement of the August-to-October rally, but the token recovered during the session as the community voted on the Veyra network upgrade.
Governance proposal IIP-717, submitted on November 12, seeks approval for software version v1.21.0. If passed, validators would halt the chain at block 193,145,000 around November 24 and restart with the updated software. Voting closes on November 16 and requires a 33.4% quorum. By November 13, participation had reached 33.03%, just 0.37 percentage points short, with 70.91% yes, 28.65% abstain, and only 0.43% no. Because abstentions count toward quorum but are excluded from the yes/no comparison, the large abstain share helps the proposal without diluting approval.
Technical indicators remain mixed. The 50-day EMA at $7.56 is well above the 200-day EMA at $6.28, keeping a golden cross in place since mid-September, but the 14-day RSI was 48.66 and volume on the bounce was about 896,000 INJ, below the spikes seen in September and October. Resistance sits at $8.13, with further upside toward $8.77 and the October peak near $9.41; a closing break below $7.33 would shift attention to support at $6.69 and then $6.04.
Veyra is designed to add institutional trading tools without changing INJ's supply or staking rewards. Its core is a request-for-quote system that lets large traders obtain firm quotes from market makers before executing, reducing slippage. The upgrade also expands atomic swaps so both legs of a transaction settle simultaneously, and adds Inter-Blockchain Communication functions to Injective's MultiVM setup for cross-chain asset movement. Any effect on INJ would have to come from higher usage and fees.
On-chain metrics show Injective's total value locked at about $20.35 million against a market capitalization near $724 million. Canary Capital's staked Injective ETF, trading on Nasdaq as INJC since November 5, held roughly $16.12 million in net assets a day after launch. Veyra also lays groundwork for the CypherOS privacy layer, and Injective's Institutional Rail, launched November 2, is seen as a likely early channel for RFQ activity, with enterprise validators including Google Cloud, Deutsche Telekom, Kraken, and BitGo.
